Vision: Towards personalized therapy for cancer; integrated molecular and epidemiological studies to reduce risk, achieve early diagnosis, improve prognosis, and tailor the treatment for breast, lung, pancreatic and ovarian cancer.
The departments overall research goals are:
Our goal is to follow the linear time course of predisposition, initiation, early stages and advanced disease and to dissect the molecular mechanisms triggered at each stage and to follow the multidimentional interactions at various levels in a systems biology approach to be able to better do risk estimation, prognostication and prediction.
To reach these goals we have divided our research into 7 activities:
Gene environment interaction in cancer risk
Tumor initiation and early diagnosis
Tumor progression and metastasis
Prediction of treatment response and targeted therapy